{"id":1930,"date":"2019-09-27T17:56:02","date_gmt":"2019-09-27T15:56:02","guid":{"rendered":"https:\/\/idibell.cat\/?page_id=1930"},"modified":"2024-03-06T11:48:48","modified_gmt":"2024-03-06T10:48:48","slug":"gynecologic-cancer-group","status":"publish","type":"page","link":"https:\/\/idibell.cat\/en\/research\/cancer-area\/molecular-mechanisms-and-experimental-therapy-in-oncology-program-oncobell\/gynecologic-cancer-group\/","title":{"rendered":"Gynecologic Cancer Group"},"content":{"rendered":"\n
The Gynaecological Cancer group is a multidisciplinary team made up of gynaecologists, oncologists, pathologists and basic researchers. The group has three leaders: Xavier Matias-Guiu, who also leads the CIBER group (CB16 \/ 12\/00231, in collaboration with IRBLLEIDA), Jordi Ponce, Mireia Martin-Satu\u00e9, David Llobet and Ruth Rodriguez-Barrueco. The group has just started working in collaboration with different areas of gynecological cancer.<\/p>\n
<\/p>\n
Herzog,C;Mar\u00edn,F;Jones,A;Evans,I;Reisel,D;Redl,E;Schreiberhuber,L et al, A Simple Cervicovaginal Epigenetic Test for Screening and Rapid Triage of Women With Suspected Endometrial Cancer: Validation in Several Cohort and Case\/Control Sets<\/strong>., J. Clin. Oncol., 2022;40(33):3828-doi:10.1200\/JCO.22.00266<\/p>\n Jim\u00e9nez,C;Antonelli,R;Nadal Ribelles,M;Devis Jauregui,L; Latorre,P; Sol\u00e9,C; Masanas,M et al, Structural disruption of BAF chromatin remodeller impairs neuroblastoma metastasis by reverting an invasiveness epigenomic program<\/strong>., Mol. Cancer, 2022;21(1):175-175, doi:10.1186\/s12943-022-01643-4<\/p>\n Muelas Fernandez,M;Lerida Urteaga,A;Paules Villar,MJ;Vidal Bel,A;Ruiz Pombo,M, Strongyloides hyperinfection in a patient from Venezuela with lower gastrointestinal bleeding<\/strong>., J. Travel Med., 2022;29(1):doi:10.1093\/jtm\/taab084<\/p>\n Rodr\u00edguez Barrueco,R;Latorre,J;Devis J\u00e1uregui,L; Lluch,A; Bonifaci,N;Llobet, FJ; livan,M et al, A microRNA Cluster Controls Fat Cell Differentiation and Adipose Tissue Expansion By Regulating SNCG<\/strong>., Adv. Sci., 2022;9(4):doi:10.1002\/advs.202104759<\/p>\n Pan\u00e9 Foix,M;Fernandez Calvo,D;Condom Mund\u00f3,I;Suarez Novo,JF;Merino Serra,E; Garcia Benett,JR; Gom\u00e0 G\u00e0llego,M et al, Clinical relevance of amyloid in prostate samples: a report on 40 patients<\/strong>., Histopathology, 2022;81(3):363-370, doi:10.1111\/his.14717<\/p>\n\t\t\t\t\tSelected Projects<\/a>\n\t\t\t\t\t\t\t\t\t\t\tExpand<\/i><\/a>\n\t\t\t\t\t 17ACL120. A PHASE IA\/B OPEN-LABEL, DOSE-ESCALATION STUDY OF THE SAFETY AND PHARACOKINETICS OF MTIG7192A AS A SINGLE AGENT AND INCOMBINATION WITH ATEZOLIZUMAB IN PATIENTS WITH LOCALLY ADVANCED OR METASTATIC TUMORS<\/strong>. Genentech, Inc. Budget: 619866. 2017-2026. PI: Gil Martin, Marta.<\/p>\n 19PSJ014. TARGETING THE AUTORESISTOME AS A NEW THERAPEUTIC STRATEGY IN ENDOMETRIAL CANCER<\/strong>. Asociaci\u00f3n Espa\u00f1ola Contra el C\u00e1ncer (AECC). Budget: 299849,22. 2019-2023. PI: Llobet Nav\u00e0s, David.<\/p>\n 17ACL048. ESTUDIO DE FASE IB, ABIERTO Y MULTIC\u00c9NTRICO, PARA CARACTERIZAR LA SEGURIDAD, TOLERABILIDAD Y FARMACODIN\u00c1MICA (PD) DE PDR001 EN COMBINACI\u00d3N CON CJM112, EGF816, ILARIS (CANAKINUMAB) O MEKINIST (TRAMETINIB)<\/strong>. Budget: 283580. 2017- . PI: Gil Martin, Marta.<\/p>\n 18ACL156. ESTUDIO DE FASE I, ABIERTO, MULTIC\u00c9NTRICO, DE B\u00daSQUEDA DE DOSIS DE TNO155 ORAL EN PACIENTES ADULTOS CON TUMORES S\u00d3LIDOS AVANZADOS<\/strong>. Novartis Farmac\u00e9utica, S.A. Budget: 233522. 2018- . PI: Gil Martin, Marta.<\/p>\n 18PSJ022. Targeting the most aggressive type of endometrial carcinoma. Asociaci\u00f3n Espa\u00f1ola Contra el C\u00e1ncer (AECC)<\/strong>. Budget: 203000. 2018-2024. PI: Mat\u00edas-Guiu Guia, Xavier.<\/p>\n\t\t\t\t\tMore Information<\/a>\n\t\t\t\t\t\t\t\t\t\t\tExpand<\/i><\/a>\n\t\t\t\t\t The group currently has projects under way which are funded by ISCIII, MINECO and private organisations (Merck-Serono, MSD), as well as a good track record of publications in peer-reviewed journals.<\/p>\n <\/p>\nCULTIVOS 3D PERSONALIZADOS PARA SELECCI\u00d3N DE TRATAMIENTO PARA PACIENTES DE C\u00c1NCER EN MEDICINA DE PRECISI\u00d3N (PROYECTO 3D-ID)<\/strong> Gynaecological Cancer Group Summary The Gynaecological Cancer group is a multidisciplinary team made up of gynaecologists, oncologists, pathologists and basic researchers. The group has three leaders: Xavier Matias-Guiu, who also leads the CIBER group (CB16 \/ 12\/00231, in collaboration with IRBLLEIDA), Jordi Ponce, Mireia Martin-Satu\u00e9, David Llobet and Ruth Rodriguez-Barrueco. The group has just started […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":448,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"site-sidebar-layout":"no-sidebar","site-content-layout":"page-builder","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"disabled","ast-breadcrumbs-content":"","ast-featured-img":"disabled","footer-sml-layout":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"default","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""}},"footnotes":""},"publishpress_future_action":{"enabled":false,"date":"2024-05-11 04:41:53","action":"change-status","newStatus":"draft","terms":[],"taxonomy":""},"_links":{"self":[{"href":"https:\/\/idibell.cat\/en\/wp-json\/wp\/v2\/pages\/1930"}],"collection":[{"href":"https:\/\/idibell.cat\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/idibell.cat\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/idibell.cat\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/idibell.cat\/en\/wp-json\/wp\/v2\/comments?post=1930"}],"version-history":[{"count":8,"href":"https:\/\/idibell.cat\/en\/wp-json\/wp\/v2\/pages\/1930\/revisions"}],"predecessor-version":[{"id":23728,"href":"https:\/\/idibell.cat\/en\/wp-json\/wp\/v2\/pages\/1930\/revisions\/23728"}],"up":[{"embeddable":true,"href":"https:\/\/idibell.cat\/en\/wp-json\/wp\/v2\/pages\/448"}],"wp:attachment":[{"href":"https:\/\/idibell.cat\/en\/wp-json\/wp\/v2\/media?parent=1930"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
\nPI: Matias-Guiu, Xavier
\nConvocatoria Retos Colaboraci\u00f3n, expediente: RTC-2017- 6573-1
\nCoordinador: STEMTEK THERAPEUTICS, S.L.
\nMinisterio de Ciencia, Innovaci\u00f3n y Universidades, perteneciente a la Agencia Estatal de Investigaci\u00f3n (AEI).
\nCofinanciado por el Fondo Europeo de Desarrollo Regional. FEDER, una manera de hacer Europa. Promover el desarrollo tecnol\u00f3gico, la innovaci\u00f3n y una investigaci\u00f3n de calidad.\n
\n\n\t\t\t\t\n\n\t\tMatias-Guiu Guia, Xavier\n\t<\/h4>\n
\n\t\t\n\t\txmatias@idibell.cat\n\t\t<\/a>\n\t<\/h4>\n
\n\t\tPrincipal investigators\n\t<\/h2>\n\t\t\t\t\n
\n\t\tMatias-Guiu Guia, Xavier\n\t<\/h4>\n
\n\t\t\n\t\txmatias@idibell.cat\n\t\t<\/a>\n\t<\/h4>\n\t\t\t\t\n
\n\t\tMart\u00edn Satu\u00e9, Mireia\n\t<\/h4>\n
\n\t\t\n\t\tmmartin@idibell.cat\n\t\t<\/a>\n\t<\/h4>\n\t\t\t\t\n
\n\t\tPonce Sebastia, Jordi\n\t<\/h4>\n
\n\t\t\n\t\tjponce@idibell.cat\n\t\t<\/a>\n\t<\/h4>\n\t\t\t\t\n
\n\t\tLlobet Navas, David\n\t<\/h4>\n
\n\t\t\n\t\tdllobet@idibell.cat\n\t\t<\/a>\n\t<\/h4>\n\t\t\t\t\n
\n\t\tGil Martin, Marta\n\t<\/h4>\n
\n\t\t\n\t\tmgil@idibell.cat\n\t\t<\/a>\n\t<\/h4>\n\t\t\t\t\n
\n\t\tRodriguez Barrueco, Ruth\n\t<\/h4>\n
\n\t\t\n\t\trrodriguezb@idibell.cat\n\t\t<\/a>\n\t<\/h4>\n\t\t\t\t\n
\n\t\tPardo Burdalo, Beatriz\n\t<\/h4>\n
\n\t\t\n\t\tbpardo@idibell.cat\n\t\t<\/a>\n\t<\/h4>\n
\n\t\tRELATED LINKS\n\t<\/h4>\n
\n\t\t\n\t\t@xmatiasguiu\n\t\t<\/a>\n\t<\/h4>\n
\n\t\t\n\t\t@DLN_Lab\n\t\t<\/a>\n\t<\/h4>\n
\n\t\t\n\t\t@RRdguezBarrueco\n\t\t<\/a>\n\t<\/h4>\n
\n\t\tTeam\n\t<\/h2>\n\t\t\t\t\t\t\t\t\t\t\t\tGroup leaders \t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\tPrincipal investigators\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\tClinical researchers \t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\tPostdoctoral researchers\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\tPredoctoral researchers\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\tScientific support\t\t\t\t<\/a>\n\t\t\t\t\t\tGroup leaders \n\t\t\t\t\t\t\t\t\t\t\t
\n
\n
\n
\n
\n
\n
\n\t\tRelated news\n\t<\/h2>\n\t\t\n\t\t\t\t<\/a>\n\t\t\tNew mouse models boost personalized treatment research in endometrial cancer<\/a>\n\t\t\tBy comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t29\/11\/2022\t\t\t\t\t\t\t\n\t\t\n\t\t\t\t<\/a>\n\t\t\tA study of IDIBELL and IDIBGI evaluates the efficacy of an anti-tumour drug against obesity<\/a>\n\t\t\tBy comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t01\/08\/2022\t\t\t\t\t\t\t\n\t\t\n\t\t\t\t<\/a>\n\t\t\tA study demonstrates the good results of cervical cancer robotic surgery<\/a>\n\t\t\tBy comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t07\/03\/2022\t\t\t\t\t\t\t\n\t\t\n\t\t\t\t<\/a>\n\t\t\tResearchers identify the molecule that could be involved in the formation of bone metastases in prostate cancer<\/a>\n\t\t\tBy comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t25\/01\/2022\t\t\t\t\t\t\t\n\t\t\n\t\t\t\t<\/a>\n\t\t\tResearchers discover a new genetic regulation pathway associated with obesity<\/a>\n\t\t\tBy comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t20\/12\/2021\t\t\t\t\t\t\t\n\t\t\n\t\t\t\t<\/a>\n\t\t\tmiR-424~503, a group of microRNAs that control the development of a type of breast cancer<\/a>\n\t\t\tBy comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t14\/10\/2021\t\t\t\t\t\t\t\n\t\t\n\t\t\t\t<\/a>\n\t\t\tDr. Xavier Matias-Guiu, the new president of the International Society of Gynecological Pathologists<\/a>\n\t\t\tBy comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t19\/03\/2021\t\t\t\t\t\t\t\n\t\t\n\t\t\t\t<\/a>\n\t\t\tDavid Llobet and Eva Gonz\u00e1lez Su\u00e1rez receive AECC grants on World Cancer Research Day<\/a>\n\t\t\tBy Idibell<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t24\/09\/2019\t\t\t\t\t\t\t\n\t\t\n\t\t\t\t<\/a>\n\t\t\tMolecular analysis could improve the early detection and prevention of endometrial cancer<\/a>\n\t\t\tBy Idibell<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t17\/06\/2019\t\t\t\t\t\t\t\n\t\t\n\t\t\t\t<\/a>\n\t\t\tThe PhD day showcases the talent of young researchers of Bellvitge<\/a>\n\t\t\tBy Idibell<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t12\/04\/2019\t\t\t\t\t\t\t\n\t\t\n\n","protected":false},"excerpt":{"rendered":"